Terms: = Ovarian cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Treatment
10 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.
Biswas S; Mandal G; Anadon CM; Chaurio RA; Lopez-Bailon LU; Nagy MZ; Mine JA; Hänggi K; Sprenger KB; Innamarato P; Harro CM; Powers JJ; Johnson J; Fang B; Eysha M; Nan X; Li R; Perez BA; Curiel TJ; Yu X; Rodriguez PC; Conejo-Garcia JR
Immunity; 2023 Nov; 56(11):2570-2583.e6. PubMed ID: 37909039
[TBL] [Abstract] [Full Text] [Related]
3. ovarian juvenile granulosa cell tumors with Ollier's disease in children with idh1 gene somatic mutation.
Zhang J; Hua R; Ma L; Liu C; Zhang Y; Lü X; Wang T; Wan N
Front Endocrinol (Lausanne); 2023; 14():1093273. PubMed ID: 37324278
[TBL] [Abstract] [Full Text] [Related]
4. Mismatch repair-deficient glioma with spatially distinct idh-mutant and idh-wild type components arising in the setting of Lynch syndrome.
Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
[TBL] [Abstract] [Full Text] [Related]
5. Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity.
Wei Z; Ye S; Feng H; Zeng C; Dong X; Zeng X; Zeng L; Lin X; Liu Q; Yao J
Cancer Sci; 2022 Sep; 113(9):3032-3043. PubMed ID: 35730256
[TBL] [Abstract] [Full Text] [Related]
6. BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme.
Xavier MA; Rezende F; Titze-de-Almeida R; Cornelissen B
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439854
[TBL] [Abstract] [Full Text] [Related]
7. Differential expression of the BCAT isoforms between breast cancer subtypes.
Shafei MA; Flemban A; Daly C; Kendrick P; White P; Dean S; Qualtrough D; Conway ME
Breast Cancer; 2021 May; 28(3):592-607. PubMed ID: 33367952
[TBL] [Abstract] [Full Text] [Related]
8. PARP goes the weasel! Emerging role of PARP inhibitors in acute leukemias.
Fritz C; Portwood SM; Przespolewski A; Wang ES
Blood Rev; 2021 Jan; 45():100696. PubMed ID: 32482307
[TBL] [Abstract] [Full Text] [Related]
9. Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas.
Stegmann S; Werner JM; Kuhl S; Röhn G; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
Anticancer Res; 2019 May; 39(5):2299-2306. PubMed ID: 31092421
[TBL] [Abstract] [Full Text] [Related]
10. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract] [Full Text] [Related]
